MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder

Kai-Feng Hung1, Chung-Ji Liu2, Peng-Chih Chiu3

  • 1Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei, Taiwan.

Oral Oncology
|December 18, 2015
PubMed
Abstract

Insights

Salivary miR-21 and miR-31 can screen for oral potentially malignant disorders (OPMD). Increased miR-31 expression and epithelial dysplasia together predict OPMD recurrence or malignant transformation.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • MicroRNAs (miRNAs) show diagnostic and prognostic potential in oral cancer.
  • The role of miRNAs in oral potentially malignant disorders (OPMD) requires further investigation.

Purpose of the Study:

  • To assess if miR-21 and miR-31 are prognostic factors for OPMD progression.
  • To evaluate the utility of salivary miR-21 and miR-31 as screening tools for OPMD.

Main Methods:

  • Quantitative reverse transcription PCR and in situ hybridization analyzed miR-21 and miR-31 in saliva and tissue samples from OPMD patients.
  • Kaplan-Meier survival analysis and Cox-proportional hazard models assessed the correlation between miRNA levels and OPMD progression.

Main Results:

  • Salivary miR-21 and miR-31 expression were significantly increased in OPMD patients compared to controls.
  • Elevated miR-31 expression in the epithelium correlated with OPMD recurrence and malignant transformation.
  • Increased miR-31 expression and epithelial dysplasia were independent risk factors for OPMD progression.

Conclusions:

  • Salivary miR-21 and miR-31 are effective OPMD screening tools.
  • Epithelial dysplasia and miR-31 upregulation synergistically predict OPMD recurrence and/or malignant transformation.
  • miR-31 detection serves as an adjuvant method for screening high-risk OPMD.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
36
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K